97 results
Page 2 of 5
8-K
EX-99.1
bg0nmpz
24 Feb 22
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results
4:27pm
8-K
EX-99.1
z1jkuw1x5ncjfe
4 Nov 21
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2021 Financial Results
4:07pm
8-K
EX-99.2
w9agax
27 May 21
GSK and Vir Biotechnology Announce Sotrovimab (VIR-7831) Receives
4:55pm
8-K
q1kw7kp yt
27 May 21
GSK and Vir Biotechnology Announce Sotrovimab (VIR-7831) Receives
4:55pm
8-K
EX-99.1
5tlraw8li7pf4 yclk31
27 May 21
GSK and Vir Biotechnology Announce Sotrovimab (VIR-7831) Receives
4:55pm
8-K
2wzgf52 r2
24 May 21
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-99.1
0njqt158iq1x1lacnedm
21 May 21
CORRECTION — EMA Issues Positive Scientific Opinion on GSK and Vir Biotechnology’s
3:38pm
8-K
EX-99.1
ghlc2k
6 May 21
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2021 Financial Results
4:24pm
8-K
EX-99.1
ogeetxd4vc dwai
13 Apr 21
Other Events
4:06pm
8-K
EX-99.1
k8n mbvxo1brkzivg
25 Feb 21
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2020 Financial Results
4:15pm
8-K
EX-99.1
6vjsex6rwg5
19 Feb 21
GSK and Vir Biotechnology Expand Coronavirus Collaboration to Advance New Therapeutics for Influenza and Other Respiratory Viruses
5:03pm